Daiichi Sankyo
199
$80.079876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$80.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.17 (+0.21%) Today
$0.00 (0.00%) As of 4:28 PM EDT after-hours
Why Robinhood?
You can buy or sell Daiichi Sankyo and other stocks, options, ETFs, and crypto commission-free!
About DSNKY
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. Read More The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan. DSNKY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
CEO
Employees
15,348
Headquarters
Tokyo, Tokyo
Founded
2005
Market Cap
51.89B
Price-Earnings Ratio
43.25
Dividend Yield
—
Average Volume
10.60K
High Today
$81.00
Low Today
$79.43
Open Price
$81.00
Volume
11.61K
52 Week High
$92.93
52 Week Low
$48.34